Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression

Journal of Psychiatry and Neuroscience

Volumn 28, Issue 3, 2003, Pages 210-216

  Bschor, Tom ^a   Baethge, Christopher ^b   Adli, Mazda ^c   Lewitzka, Ute ^a   Eichmann, Uta ^a   Bauer, Michael ^c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b MCLEAN HOSPITAL   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Antidepressive agents; Depressive disorder; Drug therapy, combination; Lithium carbonate; Thyrotropin; Thyroxine; Treatment outcome; Triiodothyronine

Indexed keywords

LIOTHYRONINE; LITHIUM; THYROTROPIN; THYROXINE; LITHIUM CARBONATE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINOLOGY; FEMALE; FOLLOW UP; HUMAN; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; LIOTHYRONINE BLOOD LEVEL; MAJOR DEPRESSION; MALE; PATIENT; PROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT FAILURE; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; THYROID GLAND;

ADULT; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LITHIUM CARBONATE; MALE; PITUITARY-ADRENAL SYSTEM; THYROID GLAND;

EID: 0037831120     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. de Montigny C, Grunberg F, Mayer A, Deschenes JP. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 1981;138:252-6.
2. Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatr 2002;3:5-43.
3. Joffe RT, Singer W, Levitt AJ, MacDonald C. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 1993;50:387-93.
4. Katona CLE, Abou-Saleh MT, Harrison DA, Nairac BA, Edwards DRL, Lock T, et al. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 1995;166:80-6.
5. Baumann P, Nil R, Souche A, Montaldi S, Baettig D, Lambert S, et al. A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation. J Clin Psychopharmacol 1996;16:307-14.
6. Bauer M, Bschor T, Kunz D, Berghöfer A, Ströhle A, Müller-Oerlinghausen B. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am J Psychiatry 2000;157:1429-35.
7. Bschor T, Berghöfer A, Ströhle A, Kunz D, Adli M, Müller-Oerlinghausen B, et al. How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression. J Clin Psychopharmacol 2002;22:427-30.
8. de Montigny C. Lithium addition in treatment-resistant depression. Int Clin Psychopharmacol 1994;9 (suppl 2):31-5.
9. Bauer M, Döpfmer S. Lithium augmentation in treatment-resistant depression - a meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 1999;19:427-34.
10. Joffe RT, Sokolov STH. Thyroid hormones, the brain, and affective disorders. Crit Rev Neurobiol 1994;8:45-63.
11. Hendrick V, Altshuler L, Whybrow P. Psychoneuroendocrinology of mood disorders. The hypothalamic-pituitary-thyroid axis. Psychiatr Clin North Am 1998;21:277-92.
12. Marangell LB, Callahan AM. Mood disorders and the thyroid axis. Curr Opinion Psychiatry 1998;11:67-70.
13. Bauer M, Whybrow PC. Thyroid hormone, neural tissue and mood modulation. World J Biol Psychiatry 2001;2:57-67.
14. Cole DP, Thase ME, Mallinger AG, Soares JC, Luther JF, Kupfer DJ, et al. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am J Psychiatry 2002;159:116-21.
15. Joffe RT, Levitt AJ, Bagby RM, MacDonald C, Singer W. Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic non-responders. Br J Psychiatry 1993;163:574-8.
16. Rybakowski JK, Suwalska A, Chlopocka-Wozniak M. Potentiation of antidepressants with lithium or carbamazepine in treatment-resistant depression. Neuropsychobiology 1999;40:134-9.
17. Schöpf J, Lemarchand T. Lithium addition in endogenous depressions resistant to tricyclic antidepressants or related drugs: relation to the status of the pituitary-thyroid axis. Pharmacopsychiatry 1994;27:198-201.
18. Bschor T, Canata B, Müller-Oerlinghausen B, Bauer M. Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression. J Affect Disord 2001;64:261-5.
19. Bschor T, Adli M, Baethge C, Eichmann U, Ising M, Uhr M, et al. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression. Neuropsychopharmacology 2002;27:470-8.
20. Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. SKID-I. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. Göttingen: Hogrefe; 1997.
21. Adli M, Berghöfer A, Linden M, Helmchen H, Müller-Oerlinghausen B, Mackert A, et al. Effectiveness and feasibility of a standardized stepwise drug treatment algorithm for inpatients with depressive disorders: results of a two-year observational study. J Clin Psychiatry 2002;63:782-90.
22. Linden M, Helmchen H, Mackert A, Müller-Oerlinghausen B. Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed inpatients. Pharmacopsychiatry 1994;27(Suppl):51-3.
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
24. Baumgartner A, Gräf KJ, Kürten I, Meinhold H. The hypothalamic-pituitary-thyroid axis in psychiatric and healthy subjects: parts 1-4. Psychiatr Res 1988;24:271-332.
25. Kirkegaard C, Faber J. Altered serum levels of thyroxine, triiodothyronines and diiodothyronines in endogenous depression. Acta Endocrinol (Copenh) 1981;96:199-207.
26. Roy-Byrne PP, Joffe RT, Uhde TW, Post RM. Carbamazepine and thyroid function in affectively ill patients. Clinical and theoretical implications. Arch Gen Psychiatry 1984;41:1150-3.
27. Joffe RT, Blank DW, Post RM, Uhde TW. Decreased triiodothyronines in depression: a preliminary report. Biol Psychiatry 1985;20:922-5.
28. Kleiner J, Altshuler L, Hendrick V, Hershman JM. Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. J Clin Psychiatry 1999;60:249-55.
29. Lazarus JH. The endocrinological effects of lithium. In: Birch NJ, Padgham C, Hughes MS, editors. Lithium in medicine and biology. Lancashire (UK): Marius Press; 1993. p. 127-31.
30. Lazarus JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 1998;8:909-13.
31. Myers DH, Carter RA, Burns BH, Armond A, Hussain SB, Chengapa VK. A prospective study of the effects of lithium on thyroid function and on the prevalence of antithyroid antibodies. Psychol Med 1985;15:55-61.
32. Bocchetta A, Bernardi F, Pedditzi M, Loviselli A, Velluzzi F, Martino E, et al. Thyroid abnormalities during lithium treatment. Acta Psychiatr Scand 1991;83:193-8.
33. Lombardi G, Panza N, Biondi B, Di Lorenzo L, Lupoli G, Muscettola G, et al. Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: a longitudinal study. J Endocrinol Invest 1993;16:259-63.
34. Frye MA, Denicoff KD, Bryan AL, Smith-Jackson EE, Ali SO, Luckenbaugh D, et al. Association between lower serum-free T4 and greater mood instability and depression in lithium-maintained bipolar patients. Am J Psychiatry 1999;156:1909-14.
35. Grof E, Grof P, Brown GM, Downie S. Lithium effects on neuroendocrine function. Prog Neuropsychopharmacol Biol Psychiatry 1984;8:541-6.
36. Perrild H, Hegedues L, Arnung K. Sex related goitrogenic effect of lithium carbonate in healthy young subjects. Acta Endocrinologica 1984;106:203-8.
37. Gyulai L, Bauer M, Bauer MS, García-España F, Cnaan A, Whybrow PC. Thyroid hypofunction in patients with rapid cycling bipolar disorder after lithium challenge. Biol Psychiatry. In press.